INT MEDICAL implements the acquisition of Hangzhou Weiqiang Medical 51.7% at a cost of 324 million RMB
INT MEDICAL (01501.HK) announced the acquisition of 51.7% equity in Hangzhou Weiqiang Medical Technology from an independent third party, which mainly engages in the research, development, manufacturing, and sales of aortic and peripheral vascular interventional medical devices, for a cash consideration of RMB 324 million
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments